Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 28,725 | 25,542 | 25,032 | 20,710 | 20,933 |
| Operating Income | -28,725 | -25,542 | -25,032 | -20,710 | -20,933 |
| Other Income | 45 | 2,843 | 4,546 | 1,671 | -16 |
| Pre-tax Income | -28,680 | -22,699 | -20,487 | -19,039 | -20,949 |
| Income Tax | 79 | 95 | 72 | 65 | 39 |
| Net Income Continuous | -28,759 | -22,794 | -20,559 | -19,103 | -20,988 |
| Net Income | $-28,759 | $-22,794 | $-20,559 | $-19,103 | $-20,988 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.30 | -0.33 | -0.39 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.30 | -0.33 | -0.39 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.30 | -0.33 | -0.39 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.30 | -0.33 | -0.39 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.30 | -0.30 | -0.33 | -0.39 |
| EBITDA(a) | $-28,655 | $-25,455 | $-24,734 | $-20,408 | $-20,572 |